Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Abbott Laboratories (ABT) P/E ratio

As of 25 September 2026, Abbott Laboratories (ABT) trades at a P/E ratio of 32.8×. Over the past ten years it has ranged from 12.4× (February 2016) to 254× (June 2018); the current reading is higher than 43% of that period. That is above the Medical Devices industry median of 22.2× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 33.7× 127.79%
FY2024 14.8× (56.12%)
FY2023 33.7× 20.23%
FY2022 28.0× (21.54%)
FY2021 35.7× (18.44%)
FY2020 43.8× 3.87%
FY2019 42.2× (22.47%)
FY2018 54.4× (75.95%)
FY2017 226× 438.51%
FY2016 42.0× 173.01%

Quarterly

Period P/E ratio Change
Jun 2026 29.4× 2.11%
Mar 2026 28.8× (14.61%)
Dec 2025 33.7× 100.66%
Sep 2025 16.8× (1.52%)
42 more quarters

Against its own ten years

Low 12.4× High 254×
Ten-year median 34.5×
Current reading's percentile 43

P/E ratio against peers

Company P/E ratio
GEHC GE HealthCare Technologies Inc. compare 15.3×
BSX Boston Scientific Corporation compare 17.7×
PHG Koninklijke Philips N.V. compare 18.2×
MDT Medtronic PLC compare 21.7×
STE STERIS plc compare 25.4×
SYK Stryker Corporation compare 28.0×
ABT Abbott Laboratories 32.8×
DXCM DexCom, Inc. compare 33.4×
EW Edwards Lifesciences Corporation compare 49.6×
Medical Devices industry median 22.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ABT